Tada Hiroomi 4
4 · Tyra Biosciences, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Common Stock
2023-03-15$6.58/sh+1,893$12,454→ 83,130 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.